The Immune Dysregulation Program at CHOP partnered with national leaders in the field of immune dysregulation to host the 7th Annual CHOP Immune Dysregulation Symposium on April 30, 2025, at the HUB for Clinical Collaboration at Children’s Hospital of Philadelphia (CHOP).
During the full-day, hybrid event, clinicians, researchers and caregivers of patients with complex multi-organ immune disease came together to explore immune dysregulation driven by infection. Symposium speakers reviewed knowledge on disease pathogenesis and best practices for therapeutics through cutting-edge talks, debating therapeutic decision-making and discussing provocative cases.
Keynote addresses were made by leaders in the field including:
- Jeffrey I. Cohen, MD, Chief of Laboratory of Infectious Disease and of the Medical Virology Section at the National Institutes of Health
- Manish Butte, MD, PhD, Division Chief of Immunology, Allergy, and Rheumatology and professor with tenure in the Department of Pediatrics at University of California, Los Angeles
- Carolina Lopez, PhD, Professor of Environmental Medicine and BJC Investigator in the Department of Molecular Microbiology at the Washington University School of Medicine in St. Louis.
- Irini Sereti, MD, PhD, Chief of Laboratory of Immunoregulation and Infectious Diseases, Senior Investigator and Chief of HIV Pathogenesis Section, NIAID/NIH
Seminar participants:
- Deepened their understanding of treatment approaches for immune dysregulation conditions
- Discussed interactions between pathogens and host responses that drive immune dysregulation
- Reviewed organ system involvement in immune dysregulation
CHOP’s Immune Dysregulation Symposium preceded the Clinical Immunology Society meeting in Philadelphia.
About the Immune Dysregulation Program
CHOP’s Immune Dysregulation Program offers patients multidisciplinary expertise, innovative diagnostic and genetic testing, and collaborative and innovative research into the genes and causes of immune dysregulation syndromes. While immune dysregulation disorders are rare, complex and difficult to diagnose, if children are diagnosed quickly and accurately, treatment can be possible.
Featured in this article
Specialties & Programs
The Immune Dysregulation Program at CHOP partnered with national leaders in the field of immune dysregulation to host the 7th Annual CHOP Immune Dysregulation Symposium on April 30, 2025, at the HUB for Clinical Collaboration at Children’s Hospital of Philadelphia (CHOP).
During the full-day, hybrid event, clinicians, researchers and caregivers of patients with complex multi-organ immune disease came together to explore immune dysregulation driven by infection. Symposium speakers reviewed knowledge on disease pathogenesis and best practices for therapeutics through cutting-edge talks, debating therapeutic decision-making and discussing provocative cases.
Keynote addresses were made by leaders in the field including:
- Jeffrey I. Cohen, MD, Chief of Laboratory of Infectious Disease and of the Medical Virology Section at the National Institutes of Health
- Manish Butte, MD, PhD, Division Chief of Immunology, Allergy, and Rheumatology and professor with tenure in the Department of Pediatrics at University of California, Los Angeles
- Carolina Lopez, PhD, Professor of Environmental Medicine and BJC Investigator in the Department of Molecular Microbiology at the Washington University School of Medicine in St. Louis.
- Irini Sereti, MD, PhD, Chief of Laboratory of Immunoregulation and Infectious Diseases, Senior Investigator and Chief of HIV Pathogenesis Section, NIAID/NIH
Seminar participants:
- Deepened their understanding of treatment approaches for immune dysregulation conditions
- Discussed interactions between pathogens and host responses that drive immune dysregulation
- Reviewed organ system involvement in immune dysregulation
CHOP’s Immune Dysregulation Symposium preceded the Clinical Immunology Society meeting in Philadelphia.
About the Immune Dysregulation Program
CHOP’s Immune Dysregulation Program offers patients multidisciplinary expertise, innovative diagnostic and genetic testing, and collaborative and innovative research into the genes and causes of immune dysregulation syndromes. While immune dysregulation disorders are rare, complex and difficult to diagnose, if children are diagnosed quickly and accurately, treatment can be possible.
Contact us
Immune Dysregulation Program